Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing by François, Moïra et al.
      Correspondence:   Jacques Galipeau  , MD, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA. E-mail: jgalipe@emory.edu         
  (Received     29     May     2011    ; accepted     12     September     2011    ) 
     Cryopreserved mesenchymal stromal cells display impaired 
immunosuppressive properties as a result of heat-shock response 
and impaired interferon-  g   licensing                   
        MO  Ï  RA         FRAN  Ç  OIS    1,2    ,             IAN B.         COPLAND    3    ,             SHALA         YUAN    2    ,   
          RAPHA  Ë  LLE         ROMIEU-MOUREZ    2    ,             EDMUND K.         WALLER    3       &     
          JACQUES         GALIPEAU    2,3,4     
    1    Department of Experimental Medicine, McGill University, Montréal, Canada,     2    Lady Sir Mortimer B. Davis Jewish 
General Hospital and Lady Davis Institute for Medical Research, Montr      é  al, Canada,     3    Department of 
Hematology and Medical Oncology, and     4    Department of Pediatrics, Emory University Winship Cancer Institute, 
Atlanta, Georgia, USA                                                           
  Abstract 
  Human mesenchymal stromal cells (MSC) can suppress T-cell activation   in vitro   in an indoleamine 2,3-dioxygenase 
(IDO)-dependent manner. However, their clinical effects on immune ailments have been inconsistent, with a recent phase 
III study showing no beneﬁ  t in acute graft-versus-host disease (GvHD). We here tested the hypothesis that the banked, 
cryopreserved MSC often used in clinical trials display biologic properties distinct from that of MSC in the log phase of 
growth typically examined in pre-clinical studies. In freshly thawed cryopreserved MSC derived from normal human 
volunteers, we observed that MSC up-regulate heat-shock proteins, are refractory to interferon (IFN)-  γ  -induced up-
regulation of IDO, and are compromised in suppressing CD3/CD28-driven T cell proliferation. Immune suppressor 
activity, IFN-  γ   responsiveness and induction of IDO were fully restored following 24 h of MSC tissue culture post-thaw. 
These results highlight a possible cause for the inefﬁ  cacy of MSC-based immunotherapy reported in clinical trials using 
cryopreserved MSC thawed immediately prior to infusion.   
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    Introduction 
  One mechanism by which human bone marrow-
derived mesenchymal stromal cells (MSC) sup-
press T-cell proliferation   in vitro   is mediated by 
the induction of indoleamine 2,3-dioxygenase 
(IDO) (1,2). Because of their ability to inhibit 
activated T cells speciﬁ  cally, MSC have been the 
subject of phase I/II trials for their potential use 
as a cell-based immunotherapeutic for the treat-
ment of autoimmune and alloimmune disorders 
(3  –  6). Clinical studies have demonstrated that the 
administration of autologous or allogeneic MSC is 
safe, and numerous phase II studies have suggested 
encouraging potency, particularly in the treat-
ment of steroid-resistant graft-versus-host disease 
(GvHD) (7). However, therapeutic effectiveness 
of MSC is not universally observed (6), including 
the results of a large phase III trial of major histo-
compatibility complex (MHC)-unmatched alloge-
neic MSC for GvHD recently completed in the 
USA (8). 
  The current model for MSC-based immuno-
therapy is to expand cells   ex vivo  , cryogenically bank 
them until needed, then administer thawed MSC 
intravenously to the patient. Until now, the effect 
of cryopreservation recovery on the immunosup-
pressive  properties of MSC has not been investi-
gated. With the present study, we demonstrate that 
freshly thawed MSC are unable to suppress T-cell 
proliferation   in vitro  , which correlates with impaired 
up-regulation of IDO in response to interferon (IFN)- γ  . 
These observations provide some insight on the incon-
sistencies between the pre-clinical and clinical utility of 
MSC for treatment of immune ailments.     
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  Methods   
  Cells 
  Human MSC were isolated and cultured as 
described elsewhere (9). After the third passage, 
the MSC cultures were assayed by ﬂ  ow cytometry 
analysis for the absence of CD45          and CD31          
contaminating cells and expression of CD44, CD73, 
CD90 and CD105 (BD Bioscience, Mississauga, 
ON, Canada), and subjected to a differentiation 
assay toward adipocyte and osteocyte lineages, as 
described elsewhere (10). Human peripheral blood 
mononuclear cells (PBMC) were isolated from leu-
kapheresis obtained from healthy volunteers using 
a Ficoll density   gradient.     
  Cell viability 
  Frozen MSC were thawed, washed in media and 
cultured for 4 h, 24 h or 7 days before all cells, ﬂ  oat-
ing and adherent, were analyzed using an annexin V 
and propidium iodide (PI) staining kit (Invitrogen, 
Burlington, ON, Canada) and quantiﬁ  ed by ﬂ  ow 
cytometry. Trypan blue exclusion staining was also 
carried out in parallel, and a consistently greater 
  ‘  viability  ’   assessment was observed compared with 
annexinV/PI staining (trypan blue viability     80%, 
annexinV/PI viability      60%, immediately after 
thawing). We believe this is due to the fact that 
trypan blue staining only shows dead cells and 
does not include dying cells; therefore trypan blue 
values were disregarded.     
  T cell proliferation assay 
  Carboxyﬂ   uorescein succinimidyl ester (CFSE; 
Invitrogen)-labeled PBMC were cultured at 
400 000 cells/well in a 24-well plate with cultured, 
freshly thawed or paraformaldehyde (PFA)-ﬁ  xed 
MSC at a ratio of MSC:PBMC of 1:3 and 1:9. T 
lymphocytes were stimulated using 0.4   μ  g/mL anti-
human CD3 and CD28 antibodies (clone HIT3a 
and CD28.2, respectively, from BD Pharmagen, 
Mississauga, ON, Canada). T-cell proliferation was 
determined 4 days later by ﬂ  ow cytometry analysis 
of CFSE ﬂ  uorescence intensity.     
  Western blot 
  Anti-human IDO (GenScript, Piscataway, NJ, USA) 
and anti-human phospho-STAT-1 (clone 58D6; Cell 
Signaling, Pickering, ON, Canada) -speciﬁ  c antibod-
ies were used to detect protein expression on whole 
cell protein extracts isolated from MSC by immuno-
blot analysis. Where indicated, MSC were activated 
with recombinant human IFN-  γ   (5 ng/mL; R&D 
System, Burlington, ON, Canada).     
  Real-time quantitative polymerase chain reaction 
  DNA-free total RNA was extracted and reverse tran-
scribed as described elsewhere (10). Real-time quan-
titative polymerase chain reaction (qPCR) assays were 
performed in duplicate on an ABI 7500 fast real-time 
PCR system thermal cycler and SYBR green master-
mix (Applied Biosystems, Carlsbad, CA, USA) with 
human primer sequences (5  ′  3  ′   forward, reverse) for: 
IDO, GCCCTTCAAGTGTTTCACCAA, CCAGCC
AGACAAATATATGCGA; Chemokine (C-C motif) 
ligand 2 (CCL2), CAAGCAGAAGTGGGTTCAG-
GAT, TCTTCGGAGTTTGGGTTTGC; interleukin  
(IL-6), ATGAAGTTCCTCTCTGCAAGAGACT, 
CACTAGGTTTGCCGAGTAGATCTC; heat shock 
protein (Hsp27), CTGGCGCGTGTCCCTGGATG, 
GCTAGCTTGGGCATGGGGGC; Hsp47, CTGC
TAGTCAACGCCATGTTCTTC, TCTGTGTCCA
ACTCAAAGGC; Hsp56, TCCTCACCCCCGACG-
GTGTG, CTGGCTTGTGCTGCCTGGCT; Hsp
70A, GGTCCGGATAACGGCTAGCCT, CCACCG
GGTCGCCGAACTTG; Hsp70B, CATGCCCCG
ATCTGCCCGAAC, GCACCTTCCCGCCCAGT
TGAG; Hsp90, ATGGCTGCTTCCCAGGTGAT
GCC, ACCTCAGGCTCATGACACCAGC; 18S 
ribosomal RNA (18S), TTACCAAAAGTGGCCCA
CTA, GAAAGATGGTGAACTATGCC. Primers 
were designed using the National Center for Biotech-
nology Information (NCBI)/primer blast designing 
tool. Data were analyzed using the relative quantiﬁ  -
cation method (11).     
  Statistical analysis 
  Data are reported as mean       standard  deviation 
(SD). All calculations were carried out using Graph-
Pad Prism software (GraphPad Software, La Jolla, 
CA, USA). Comparisons between groups were made 
by   ANOVA  .       
  Results and discussion 
  To determine the immunosuppressive potential of 
cryopreserved MSC toward T-cell activation, we ana-
lyzed their potency to suppress PBMC proliferation 
in comparison with MSC maintained in culture for 
7 days. Early passage MSC were frozen in   α   Mini-
mum Essential Medium (MEM), 30% fetal bovine 
serum and 5% dimethyl sulfoxide at   –  80  °  C for 24 
h, then transferred to liquid nitrogen for 1 week 
before use. Cell viability analysis by ﬂ  ow cytometry 
using annexin V- and PI-labeling revealed that, in 
cultured MSC, the percentage of live cells (annexin 
V    –    and PI    –   ) was 92% and 91% for donors A and B, 
respectively, while in their thawed counterparts the 
percentage of live cells dropped to 61% and 44%, 
respectively (Figure 1A). We next tested post-thaw   Effect of cryopreservation of human MSC  149
cell culture restoration of immune suppressor func-
tion. Freshly thawed cryopreserved MSC and MSC 
in the log phase of growth were co-cultured with 
CFSE-labeled PBMC activated with anti-CD3 and 
-CD28 antibodies at a MSC:PBMC ratio of 1:3, and 
T-cell proliferation was measured 4 days later. Cryo-
preserved MSC had a signiﬁ  cantly impaired inhibi-
tory effect on the proliferation of activated T cells 
in comparison with their cultured counterpart 
maintained in the log phase of growth (  P       0.0001) 
(Figure 1B). T-cell hyperproliferation observed in 
the presence of thawed MSC suggested that dead 
MSC found in the freshly thawed MSC samples may 
activate T-cell proliferation. To test this hypothesis, 
we performed a T-cell proliferation assay in which 
cultured MSC were mixed at a different ratio with 
PFA-ﬁ  xed MSC, which served as dead cells, while the 
MSC:PBMC ratio remained 1:3 (Figure 1C). Adding 
increasing amounts of ﬁ  xed MSC while reducing the 
amount of live MSC diminished the level of    T-cell 
immunosuppression. Hyper-proliferation of     T cells 
could also be observed at ratios of 1:1, 1:2 and 100% 
ﬁ  xed, depending on the MSC donor, which may have 
been caused by the low amount of IDO produced in 
comparison with the pro-inﬂ  ammatory cytokines [i.e. 
interleukin (IL)-6] produced by live MSC. Four hours 
of adherent or suspension culture of MSC after thaw-
ing were not sufﬁ  cient to restore their immunosuppres-
sive capabilities (data not shown). However, a culture 
period of 24 h was sufﬁ  cient to restore the immunosup-
pressive properties of thawed MSC to a level similar to 
that of MSC cultured for 7 days (Figure 1D). 
  IFN-  γ  -inducible expression of IDO in human 
MSC has been identiﬁ  ed as one of the main mecha-
nisms of T-cell immunosuppression (2). We therefore 
tested the induction of IDO protein expression in 
MSC. Freshly thawed MSC stimulated with IFN-  γ   
showed very low levels of IDO protein expression 
compared with cultured MSC, while culture recov-
ery for at least 24 h restored IFN-  γ   responsiveness 
and IDO induction (Figure 2A). This observation 
suggests that the MSC biochemical response to 
IFN-  γ   and/or the protein synthesis machinery is 
compromised. To test this hypothesis, we analyzed 
Signal Transducers and Activators of Transcription 
(STAT-1) phosphorylation in response to IFN-  γ   
stimulation by immunoblotting, and found that 
phosphorylated STAT-1 was markedly diminished in 
thawed compared with cultured MSC (Figure 2B). 
Consistent with these data, we queried the mRNA 
transcript levels of IDO, and of two constitutively 
expressed genes, CCL2 and IL-6. No basal expres-
sion mRNA encoding of IDO was detected, while 
the basal levels of CCL2 and IL-6 mRNA gene 
expression were comparable in freshly thawed and 
cultured MSC (Figure 2C). In response to IFN-  γ  , 
the up-regulation of IDO and CCL2 mRNA expres-
sion was signiﬁ  cantly diminished in thawed MSC. 
In two individual donors, IFN-  γ  -induced levels of 
IDO mRNA decreased 2.7- and 5-fold (  P       0.001; 
Figure 2Ci), while CCL2 mRNA expression 
decreased 4- and 7-fold (  P        0.001; Figure 2Cii). 
IL-6 regulation is mainly regulated by tumor necro-
sis factor (TNF)-  α  , which appeared only slightly 
   
Figure 1.         Immunosuppressive potential of freshly thawed human 
MSC compared with MSC in culture. (A) Cell viability analysis 
was performed on freshly thawed and cultured MSC using annexin 
V and PI labeling. (B) T-cell proliferation assays were performed 
using CFSE-labeled human PBMC activated with 0.4   μ  g/mL anti-
CD3 and -CD28 antibodies and co-cultured for 4 days with or 
without MSC maintained in culture for 7 days or freshly thawed 
at a MSC:PBMC ratio of 1:3. Cell proliferation was determined 
by ﬂ  ow cytometry after gating lymphocytes on the forward and 
side scatter plot and measuring the percentage of CFSE  low   T cells. 
(C) T-cell proliferation assay performed as in (B) using cultured 
MSC mixed with PFA-ﬁ  xed MSC at a ratio of live:ﬁ  xed of 2:1, 
1:1, 1:2 or 100% ﬁ  xed. A MSC:PBMC ratio of 1:3 was used. (D) 
T-cell proliferation assays performed as in (B) on two MSC donors 
freshly thawed and cultured for 1 and 7 days. Figures show 
representative results with means       SD.  150 M.  Fran  ç  ois et al.
and Hsp90, which diminishes within 24 h (12). In 
addition, Hsp27 has been demonstrated to inhibit 
cellular protein synthesis by blocking the assembly of 
the translation cap initiation complex (13). In order 
to determine whether the transcription of Hsp genes 
is altered by stress induced by the cryopreservation 
and thawing process in MSC, we performed real-time 
affected by IFN-  γ   stimulation (Figure 2Ciii). These 
results suggest that transcript levels of constitutively 
produced proteins are not altered while transcrip-
tion of IFN-  γ  -inducible genes is. Studies performed 
on human ﬁ  broblasts have demonstrated that cryo-
preservation and thawing induces the expression of 
heat-shock proteins (Hsp) Hsp27, Hsp47, Hsp56 
   
Figure 2.         Protein and mRNA expression level of freshly thawed human MSC compared with MSC in culture. (A) IDO protein expression 
was analyzed by immunoblot on two human MSC donors freshly thawed and cultured for 1 and 7 days. IDO protein expression was 
induced by stimulating the MSC with 5 ng/mL recombinant (rh)IFN-  γ   for 24 h. Protein expression of Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as a loading control. (B) Phosphorylated STAT-1 protein expression was analyzed by immunoblot on 
two human MSC donors freshly thawed and cultured for 1 and 7 days. STAT-1 phosphorylation was induced by stimulating the MSC 
with 5 ng/mL IFN-  γ   for 20 min. Protein expression of total STAT-1 was used as a loading control. (C) mRNA expression levels of (i) 
IDO, (ii) CCL2 and (iii) IL6 were measured by real-time qPCR in two MSC donors freshly thawed and cultured for 7 days. MSC were 
left untreated or stimulated with 5 ng/mL rhIFN-  γ   for 24 h. (D) mRNA expression level of Hsp27, Hsp47, Hsp56, Hsp70A, Hsp70B and 
Hsp90 by real-time qPCR performed on three MSC donors immediately after thawing and following a post-thaw recovery period of 4, 8, 
16 and 24 h. Ribosomal 18S RNA was used as an internal control. Figures show representative results with means       SD.    Effect of cryopreservation of human MSC  151
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  In conclusion, our data demonstrate that cryo-
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of at least 24 h is able to restore the immunosup-
pressive properties of MSC, including transcriptional 
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